Humankind Investments LLC Acquires 2,776 Shares of AdaptHealth Corp. (NASDAQ:AHCO)

Humankind Investments LLC boosted its holdings in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 18.3% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,979 shares of the company’s stock after buying an additional 2,776 shares during the quarter. Humankind Investments LLC’s holdings in AdaptHealth were worth $171,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently added to or reduced their stakes in the business. Assetmark Inc. purchased a new stake in shares of AdaptHealth in the fourth quarter worth $28,000. Blue Trust Inc. increased its stake in shares of AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock worth $55,000 after purchasing an additional 1,115 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in shares of AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after purchasing an additional 1,690 shares in the last quarter. Guggenheim Capital LLC increased its stake in shares of AdaptHealth by 10.1% in the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company’s stock worth $158,000 after purchasing an additional 1,525 shares in the last quarter. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of AdaptHealth in the fourth quarter worth $169,000. 82.67% of the stock is currently owned by institutional investors.

AdaptHealth Price Performance

AHCO stock opened at $8.57 on Monday. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.90. The company has a quick ratio of 1.00, a current ratio of 1.24 and a debt-to-equity ratio of 1.34. The company has a fifty day simple moving average of $9.29 and a two-hundred day simple moving average of $9.73. The firm has a market capitalization of $1.16 billion, a P/E ratio of -5.19, a price-to-earnings-growth ratio of 1.08 and a beta of 1.64.

Analyst Ratings Changes

A number of equities analysts recently weighed in on the stock. UBS Group dropped their target price on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Truist Financial upped their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Royal Bank of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an “outperform” rating for the company in a research report on Thursday. Canaccord Genuity Group upped their target price on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Wednesday, February 26th. Finally, Robert W. Baird upped their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Thursday, February 27th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $13.60.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.